ASKA Pharmaceutical Holdings Co.,Ltd. 4886Short Interest
No institution currently reports a short position of 0.5% or more in ASKA Pharmaceutical Holdings Co.,Ltd. (4886). The last disclosure was on 2026-11-06 (Diversified Select Opportunities, LLC, 0.45%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
62 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 5 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2021-05-26 |
|---|---|
| Latest disclosure | 2026-11-06 (Diversified Select Opportunities, LLC, 0.45%) |
| Reporting institutions | 6 firms (62 reports) |
| Peak estimated short interest | 1.80% (2026-08-07, 2 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Barclays Capital Securities Ltd
- Diversified Select Opportunities, LLC
- Diversified Select Opportunities Capital Management, LLC
- Morgan Stanley MUFG Securities Co., Ltd.
- Nomura International plc
0.00%
Estimated short interest, 2026-11-18
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2024-06-25 | Diversified Select Opportunities Capital Management, LLC | Position 148,600 shares | Ratio 0.48% | ▼0.08% | Below 0.5% |
| 2026-02-05 | Nomura International plc | Position 139,735 shares | Ratio 0.48% | ▼0.02% | Below 0.5% |
| 2026-05-12 | Morgan Stanley MUFG Securities Co., Ltd. | Position 134,062 shares | Ratio 0.46% | ▼0.05% | Below 0.5% |
| 2026-11-06 | Diversified Select Opportunities, LLC | Position 130,000 shares | Ratio 0.45% | ▼0.14% | Below 0.5% |
| 2026-10-29 | Barclays Capital Securities Ltd | Position 106,689 shares | Ratio 0.37% | ▼0.32% | Below 0.5% |
| 2021-05-27 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 0 shares | Ratio 0.00% | ▼0.56% | Closed |
Disclosure History 62 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-11-06 | Diversified Select Opportunities, LLC | Position 130,000 shares | Ratio 0.45% | ▼0.14% | Below 0.5% |
| 2026-10-30 | Diversified Select Opportunities, LLC | Position 170,900 shares | Ratio 0.59% | ▼0.10% | — |
| 2026-10-29 | Barclays Capital Securities Ltd | Position 106,689 shares | Ratio 0.37% | ▼0.32% | Below 0.5% |
| 2026-10-27 | Barclays Capital Securities Ltd | Position 200,210 shares | Ratio 0.69% | ▼0.10% | — |
| 2026-10-19 | Barclays Capital Securities Ltd | Position 228,110 shares | Ratio 0.79% | ▼0.20% | — |
| 2026-10-16 | Diversified Select Opportunities, LLC | Position 200,700 shares | Ratio 0.69% | ▼0.02% | — |
| 2026-10-08 | Diversified Select Opportunities, LLC | Position 204,400 shares | Ratio 0.71% | ▲0.02% | — |
| 2026-10-08 | Barclays Capital Securities Ltd | Position 285,209 shares | Ratio 0.99% | ▼0.09% | — |
| 2026-10-01 | Barclays Capital Securities Ltd | Position 312,609 shares | Ratio 1.08% | ▲0.39% | — |
| 2026-09-29 | Diversified Select Opportunities, LLC | Position 199,600 shares | Ratio 0.69% | ▼0.01% | — |
| 2026-09-01 | Barclays Capital Securities Ltd | Position 201,034 shares | Ratio 0.69% | ▼0.09% | — |
| 2026-08-20 | Barclays Capital Securities Ltd | Position 224,834 shares | Ratio 0.78% | ▼0.21% | — |
| 2026-08-18 | Barclays Capital Securities Ltd | Position 285,634 shares | Ratio 0.99% | ▼0.11% | — |
| 2026-08-07 | Diversified Select Opportunities, LLC | Position 202,100 shares | Ratio 0.70% | ▲0.06% | — |
| 2026-08-07 | Barclays Capital Securities Ltd | Position 316,835 shares | Ratio 1.10% | ▲0.03% | — |
| 2026-08-06 | Barclays Capital Securities Ltd | Position 308,335 shares | Ratio 1.07% | ▲0.10% | — |
| 2026-08-05 | Diversified Select Opportunities, LLC | Position 186,500 shares | Ratio 0.64% | ▲0.05% | — |
| 2026-07-30 | Barclays Capital Securities Ltd | Position 281,235 shares | Ratio 0.97% | ▼0.07% | — |
| 2026-07-29 | Diversified Select Opportunities, LLC | Position 171,300 shares | Ratio 0.59% | ▼0.01% | — |
| 2026-07-22 | Diversified Select Opportunities, LLC | Position 173,200 shares | Ratio 0.60% | ▲0.01% | — |
| 2026-07-21 | Diversified Select Opportunities, LLC | Position 172,000 shares | Ratio 0.59% | ▼0.01% | — |
| 2026-07-16 | Barclays Capital Securities Ltd | Position 300,035 shares | Ratio 1.04% | ▲0.14% | — |
| 2026-07-10 | Diversified Select Opportunities, LLC | Position 172,800 shares | Ratio 0.60% | ▲0.09% | — |
| 2026-06-30 | Barclays Capital Securities Ltd | Position 261,281 shares | Ratio 0.90% | ▲0.13% | — |
| 2026-06-29 | Barclays Capital Securities Ltd | Position 247,581 shares | Ratio 0.86% | ▲0.09% | — |
| 2026-06-25 | Barclays Capital Securities Ltd | Position 223,781 shares | Ratio 0.77% | ▲0.14% | — |
| 2026-06-19 | Barclays Capital Securities Ltd | Position 182,481 shares | Ratio 0.63% | ▲0.12% | — |
| 2026-06-18 | Barclays Capital Securities Ltd | Position 147,081 shares | Ratio 0.51% | ▲0.02% | — |
| 2026-06-15 | Barclays Capital Securities Ltd | Position 142,081 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2026-06-11 | Barclays Capital Securities Ltd | Position 145,481 shares | Ratio 0.50% | ▲0.01% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| FunPep Company Limited4881 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Perseus Proteomics Inc.4882 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Modalis Therapeutics Corporation4883 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Kringle Pharma,Inc.4884 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| MUROMACHI CHEMICALS INC.4885 | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| SAWAI GROUP HOLDINGS Co.,Ltd.4887 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |
| STELLA PHARMA CORPORATION4888 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Renascience Inc.4889 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Tsubota Laboratory Incorporated4890 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| TMS Co.,Ltd.4891 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical |